Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of the CRTH2 Antagonist OC459 on the Response to Rhinovirus Challenge in Asthma

NCT02660489 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT02660489
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02660489 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of the CRTH2 Antagonist OC459 on the Response to Rhinovirus Challenge in Asthma
Lead sponsor
Imperial College London
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2015
Completion date
February 28, 2018
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma, common cold, picornaviridae infections, rhinovirus